American Society of Clinical Oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction (Q33990344)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | American Society of Clinical Oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction |
scientific article |
Statements
1 reference
American Society of Clinical Oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction (English)
1 reference
Scott M Lippman
1 reference
Kala Visvanathan
1 reference
Patricia Hurley
1 reference
Sarah Temin
1 reference
American Society of Clinical Oncology Clinical Practice Guideline
1 reference
1 October 2009
1 reference
1 reference
115
1 reference
132-134
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference